Pulzium FDA Approval Status
FDA Approved: No
Brand name: Pulzium
Generic name: tedisamil
Company: Solvay Pharmaceuticals
Treatment for: Atrial Flutter, Atrial Fibrillation
Pulzium IV (tedisamil) is a class III anti-arrhythmic drug in the later phase of clinical development for the treatment of recent onset atrial fibrillation or atrial flutter.
Development timeline for Pulzium
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.